[Skip to Navigation]
May 1970

Sleep Disturbance and Serum CPK Activity in Acute Psychosis

Author Affiliations

From the Department of Psychiatry, University of Chicago Pritzker School of Medicine and the Laboratory of Clinical Psychobiology, National Institute of Mental Health, Bethesda, Md. Dr. Kupfer is now with the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.

Arch Gen Psychiatry. 1970;22(5):398-405. doi:10.1001/archpsyc.1970.01740290014003

SINCE the nature and etiology of acute psychosis are still obscure, the establishment of any abnormal biological parameters for acutely psychotic patients, irrespective of whether such parameters relate to cause or effect of the psychosis, would be of considerable interest. Recently, severe sleep disturbances affecting both rapid-eye-movement (REM) sleep and nonrapid-eye-movement (NREM) sleep were reported in patients having psychotic depressions and acute schizophrenic episodes.1 Secondly, increased activity of creatine-phosphokinase (CPK) (ATP-creatine phosphotransferase) in serum was found in patients having recent onsets of psychosis.2-4 Both types of abnormalities seem to be present mainly at the onset of the acute psychotic episode and generally last from several days to two weeks, with occasional exceptions. It is of interest that both types of biological abnormalities are present in acutely psychotic patients of a variety of diagnostic types, including patients with manic-depressive psychosis, psychotic depressions, and

Add or change institution